This study uses single‐cell RNA sequencing in an APP/PS1 mouse model to uncover early transcriptional and cellular changes in the choroid plexus. It identifies a pronounced dysregulation in epithelial cells related to mitochondrial assembly, cilium organization, and barrier integrity, suggesting that choroid plexus dysfunction may actively contribute to Alzheimer’s disease progression
This paper, titled Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer’s disease, employs cutting-edge single-cell transcriptomics to provide novel insights into the early events of Alzheimer’s disease (AD). The authors analyze the choroid plexus (ChP) from APP/PS1 mice, comparing it with wild-type littermates to identify early dysregulation in key cellular pathways.
Strengths:
Limitations:
The insights provided by this study are particularly significant, as they shift the focus towards the choroid plexus – an often overlooked structure in AD research. By highlighting early transcriptional changes, the study opens avenues for using ChP dysfunction as a biomarker and potential therapeutic target. It further supports the idea that alterations in brain barrier functions and immune regulation are central to AD pathogenesis
This visual graph outlines how the disruption in the choroid plexus inspires downstream effects on immune response and contributes to AD pathology.